Analysis of HIF-1α and COX-2 expression in tumor stroma and correlation with the degree of neoplasm invasiveness in laryngeal cancer - Preliminary study;Analiza ekspresji HIF-1α i COX-2 w utkaniu guza oraz korelacja ze stopniem inwazyjności zmian nowotworowych u chorych z rakiem krtani - Badania wstpne

Otolaryngologia Polska

Volumn 65, Issue 5 SUPPL., 2011, Pages 102-108

  Woś, Jan ^a   Bryś, Magdalena ^b   Lewy Trenda, Iwona ^c   Stasikowska, Olga ^b   Papie, Paweł ^a   Papierz, Wielisław ^c   Starska, Katarzyna ^c  

^a Oddział Laryngologii Szpitala Im Eromskiego W Krakowie ^*  (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

COX 2; HIF 1 ; inwazyjno zmian nowotworowych; rak p askonab onkowy krtani

Indexed keywords

CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ARTICLE; CANCER GRADING; CANCER INVASION; COX 2 GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HIF 1ALPHA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CARCINOMA; MARKER GENE; MOLECULAR PATHOLOGY; MORPHOLOGICAL TRAIT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 80054072094     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6657(11)70717-X     Document Type: Article

References (20)

1. S.E. Wheeler, S. Suzuki, S.M. Thomas, M. Sen, R.J. Leeman-Neill, and S.I. Chiosea Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation Oncogene 29 37 2010 5135 5145
2. T. Fillies, R. Werkmeister, P.J. van Diest, B. Brandt, U. Joos, and H. Buerger HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor BMC Cancer 21 2005 5 84
3. A.C. Abrahao, R.M. Castilho, C.H. Squarize, A.A. Molinolo, D. dos Santos-Pinto Jr, and J.S. Gutkind A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation Oral Oncol 46 12 2010 880 887
4. M. Pandey, O. Prakash, W.S. Santhi, C.S. Soumithran, and R.M. Pillai Overexpression of COX-2 gene in oral cancer is independent of stage of disease and degree of differentiation Int J Oral Maxillofac Surg 37 4 2008 379 383 (Pubitemid 351446108)
5. B. O'Sullivan, and J. Shah New TNM staging criteria for head and neck tumors Semin Surg Oncol 21 2003 30 42 (Pubitemid 37127472)
6. K. Starska, E. Forma, I. Lewy-Trenda, O. Stasikowska, M. Bryś, and W.M. Krajewska The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma Folia Histochem Cytobiol 7 3 2009 401 410
7. R. Cabanillas, J.P. Rodrigo, P. Secades, A. Astudillo, C.S. Nieto, and M.D. Chiara The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer J Surg Oncol 99 6 2009 373 378
8. S. Jo, A. Juhasz, K. Zhang, C. Ruel, S. Loera, and S.P. Wilczynski Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial Anticancer Res 29 5 2009 467 1474
9. S.Y. Moon, H.W. Chang, J.L. Roh, G.C. Kim, S.H. Choi, and S.W. Lee Using YC-1 to overcome the radioresistance of hypoxic cancer cells Oral Oncol 45 10 2009 915 919
10. M.L. Schrijvers, B.F. van der Laan, G.H. de Bock, W.J. Pattje, M.F. Mastik, and L. Menkema Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy Int J Radiat Oncol Biol Phys 72 1 2008 61 169
11. J.P. Rodrigo, R. Cabanillas, M.D. Chiara, J. García Pedrero, M. Florentino Fresno, and C. Suárez Nieto Molecular alterations in nodal metastases and its primary tumors in squamous cell carcinomas of the larynx Acta Otorrinolaringol Esp 59 3 2008 114 119 (Pubitemid 351670815)
12. P.A. Kyzas, D. Stefanou, A. Batistatou, and N.J. Agnantis Hypoxiainduced tumor angiogenic pathway in head and neck cancer: an in vivo study Cancer Lett 225 2 2005 297 304 (Pubitemid 40835878)
13. S. Yin The expression and significance of HIF-1alpha and COX-2 in laryngeal squamous cell carcinoma Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21 18 2007 820 824
14. W. Cheng, and W. Zhou Clinical significance and relationship between HIF-1alpha, COX-2VEGF and microvessel density expression in laryngeal carcinoma Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24 18 2010 820 822
15. X.H. Wu, Y.F. Lu, X.D. Hu, J.Y. Mao, X.X. Ji, H.T. Yao, and S.H. Zhou Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma J Int Med Res 38 6 2010 2040 2046
16. P. Lin, W. Wang, W.J. Cai, C.R. Han, Y. Sun, M. Li, and B.C. Sun Relationship between the expression of hypoxia-inducible factor-1alpha and epidermal growth factor receptor and micro vessel density and their clinical significance Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44 6 2009 480 485
17. Y.Y. Kim, E.J. Lee, Y.K. Kim, S.M. Kim, J.Y. Park, H. Myoung, and M.J. Kim Anti-cancer effects of celecoxib in head and neck carcinoma Mol Cells 29 2 2010 185 194 28
18. K. Kourelis, G. Vandoros, T. Kourelis, T. Papadas, P. Goumas, and G. Sotiropoulou-Bonikou Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression Laryngoscope 119 9 2009 1723 1729
19. T. Nakagawa, H. Tanaka, T. Shirakawa, A. Gotoh, Y. Hayashi, and K. Hamada Cyclooxygenase 2 promoter-based replication- selective adenoviral vector for hypopharyngeal cancer Arch Otolaryngol Head Neck Surg 135 3 2009 282 286
20. S. Lang, S. Tiwari, M. Andratschke, I. Loehr, L. Lauffer, and C. Bergmann Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition Cancer Immunol Immunother 56 10 2007 1645 1652 (Pubitemid 47094395)